Industry News

Drug for Rare Blood Disorder Developed at Penn Receives Orphan Drug Status from the FDA
Pfizer Receives FDA Accelerated Approval for TRUMENBA� (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Adolescents and Young Adults
Xyntek And Antares Vision Unveil Turnkey Third Generation Pharmaceutical Serialization Solution at Pharma EXPO / PACK EXPO 2014
Iraq Joins USP in Global Program Regarding Medicine Quality Testing
FDA Approves Protein Sciences Flu Vaccine For Older Americans
Bristol-Myers Squibb and Lonza Expand Manufacturing Agreement
INFINEX Creates Bio Critical Solutions To Join The Fight Against Cancer And Ebola
Pfizer Receives FDA Accelerated Approval for Truemba for the Prevention of Invasive Meningococcal B Disease in Adolescents and Young Adults
FDA approves new treatment for rare form of hemophilia
Novo Nordisk now hiring for new manufacturing facility in New Hampshire
Abbott Expands Its Medical Device Business with Acquisition in Catheter-Based Electrophysiology Market Abbott Enters Large and Growing Catheter-Based Electrophysiology Market with Next-Generation Technologies to Improve Treatment of People with Atrial Fib
MHRA -Medicines watchdog makes record seizure of experimental smart drugs
Genentech Garners FDA Approval of Esbriet for Idiopathic Pulmonary Fibrosis
Zogenix Acquires U.K.-Based Brabant Pharma
Intellipharmaceutics Reports That the FDA Has Given Its Toronto Manufacturing Facility an "Acceptable" Classification
India bans plastic packaging for liquid pharmaceutical products
India bans plastic packaging for liquid pharmaceutical products
Revive Therapeutics Ltd. Applies for Orphan Drug Designation to FDA for Treatment of Rett Syndrome
Araim Pharmaceuticals Given FDA Fast Track Designation to ARA 290 for the Treatment of Sarcoidosis-associated Small Fiber Neuropathy
Revive Therapeutics Ltd. Applies for Orphan Drug Designation to FDA for Treatment of Rett Syndrome
Drug for Rare Blood Disorder Developed at Penn Receives Orphan Drug Status from the FDA
Contract Packaging Resources, Inc. Issues a Voluntary Nationwide Recall of Assured Brand Naproxen Sodium Tablets Due to Packaging Mix-Up
Arbor Pharmaceuticals Announces FDA Approval of Sotylize�
Intellipharmaceutics Reports That the FDA Has Given Its Toronto Manufacturing Facility an "Acceptable" Classification
Zogenix Acquires U.K.-Based Brabant Pharma